The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Neumora Therapeutics, Inc. insider acquisitions

Company CIK 0001885522 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
NMRA · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 22, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Burow KristinaBurow KristinaCRANDELL KEITHCRANDELL KEITHNELSEN ROBERTNELSEN ROBERTBYBEE CLINTONBYBEE CLINTONGILLIS STEVENGILLIS STEVENARCH Venture Fund XII, L.P.ARCH Venture Fund XII, L.P.ARCH Venture Partners XII, LLCARCH Venture Partners XII…ARCH Venture Partners XII, L.P.ARCH Venture Partners XII…Burow Kristina · October 27, 2025 · Purchase · Common StockCRANDELL KEITH · October 27, 2025 · Purchase · Common StockNELSEN ROBERT · October 27, 2025 · Purchase · Common StockBYBEE CLINTON · October 27, 2025 · Purchase · Common StockGILLIS STEVEN · October 27, 2025 · Purchase · Common StockARCH Venture Fund XII, L.P. · October 27, 2025 · Purchase · Common StockARCH Venture Partners XII, LLC · October 27, 2025 · Purchase · Common StockARCH Venture Partners XII, L.P. · October 27, 2025 · Purchase · Common StockOct 27, 2025Oct 27, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 8 of 18 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 27, 2025Neumora Therapeutics, Inc.Common StockBurow KristinaPurchase
Oct 27, 2025Neumora Therapeutics, Inc.Common StockCRANDELL KEITH · NELSEN ROBERT · BYBEE CLINTON · GILLIS STEVEN · ARCH Venture Fund XII, L.P. · ARCH Venture Partners XII, LLC · ARCH Venture Partners XII, L.P.Purchase
Oct 27, 2025Neumora Therapeutics, Inc.Common StockARCH Venture Fund VII, L.P. · ARCH Venture Partners VII, LLC · ARCH Venture Partners VII, L.P. · ARCH Venture Partners VIII, LLC · ARCH Venture Fund VIII Overage, L.P. · ARCH Venture Fund X, L.P. · ARCH Venture Fund X Overage, L.P. · ARCH Venture Partners X Overage, L.P. · ARCH Venture Partners X, LLC · ARCH Venture Partners X, L.P.Purchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

NMRA · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Burow KristinaDirector · 10% owner
PurchaseCommon StockNon-derivative security · Code P1,915,7002.61Value: 4,999,977Currency not specifiedView ↗
Trade:
NELSEN ROBERT10% owner
BYBEE CLINTON10% owner
GILLIS STEVEN10% owner
ARCH Venture Fund XII, L.P.10% owner
ARCH Venture Partners XII, LLC10% owner
ARCH Venture Partners XII, L.P.10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P1,915,7002.61Value: 4,999,977Currency not specifiedView ↗
Trade:
ARCH Venture Partners VII, LLC10% owner
ARCH Venture Partners VII, L.P.10% owner
ARCH Venture Partners VIII, LLC10% owner
ARCH Venture Fund VIII Overage, L.P.10% owner
ARCH Venture Fund X, L.P.10% owner
ARCH Venture Fund X Overage, L.P.10% owner
ARCH Venture Partners X Overage, L.P.10% owner
ARCH Venture Partners X, LLC10% owner
ARCH Venture Partners X, L.P.10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P1,915,7002.61Value: 4,999,977Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →